Cellvizio pCLE Technology Provides More Accurate IBD Diagnoses, Leads To Better Outcomes

Cellvizio pCLE Technology Provides More Accurate IBD Diagnoses, Leads To Better Outcomes
celvisiorsCellvizio, a probe-based Confocal Laser Endomicroscopy (pCLE) system that is the flagship product of Paris, France, based Mauna Kea Technologies, should be routinely implemented to improve diagnostic evaluation and management of a number of gastric, intestinal, and biliary (liver) diseases. That's the recommendation of a major consensus report by a team of 26 experts representing research and treatment institutions in the U.S., Europe, and Scandinavia, published in the United European Gastroenterology Journal. In the paper, entitled "Use of probe-based confocal laser endomicroscopy (pCLE) in gastrointestinal applications. A consensus report based on clinical evidence" (Published online before print January 14, 2015, doi: 10.1177/2050640614566066), the coauthors note that use of the Cellvizio technology provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues. Large, international, multi-center clinical trials have demonstrated Cellvizio's ability to help physicians dete
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *